Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

AusCann Announces PCI Pharma Appointed to Manufacture its First Medicinal Cannabis Product Line (ASX:AC8)

Highlights AusCann appoints TGA licensed PCI Pharma to manufacture and release its first medicinal cannabis product line. New proprietary solid hard shell capsules for treatment of chronic pai...read more

Imugene Advances to Phase 2 in Gastric Cancer Immuno-oncology Trial (ASX:IMU)

Phase 1b study objectives met; all dose levels showed increased antibody levels in all patients Phase 2 study on track to start early 2019 Dose level confirmed for Phase 2 with no safety issu...read more

Ingenia Communities, 2018 Annual General Meeting Presentation (ASX:INA)

1. Chairman's Welcome 2. Business Update 3. Resolutions FY18 Achievements - Expansion of Lifestyle and Holidays portfolio - Capital initiatives - Development contribution increas...read more

Ingenia Communities 2018 Annual General Meeting Chairman’s Address (ASX:INA)

The 2018 financial year demonstrated the returns that would flow from taking the opportunities emerging from our strategy to focus on our lifestyle and holidays business. I am very pleased with our...read more

Ingenia Communities 2018 Annual General Meeting CEO Update (ASX:INA)

Ingenia is now in a period of accelerated growth as we build out our development pipeline in key capital city and coastal markets. We now have 10 communities under development, including Hervey Bay, a...read more

Noxopharm to Present Clinical Data at COSA 2018 Annual Meeting (ASX:NOX)

Clinical Oncology Society of Australia Provides updates on CEP-1 and DARRT-1 clinical studies Confirms tolerability of Veyonda Evidence of durable halt of tumour progression in both studi...read more

Managed Accounts Holdings, September 2018 Quarterly Business Update (ASX:MGP)

Highlights - Acquisition of Aracon Superannuation Pty Ltd - Combined group Funds under Administration (FUA) as at 30 September 2018 was $13.77 billion - Combined group gross inflows of $516.6...read more

Altech Chemicals Advises Withdrawal of Resolution from Annual General Meeting (ASX:ATC)

Altech Chemicals Limited (Altech/the Company) (ASX:ATC) (FRA:A3Y) advises that the directors, after giving due consideration to a recent deterioration of global equity markets, have resolved to withdr...read more

Immutep Presents Positive New Data from Ongoing TACTI-mel Study at Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting (ASX:IMM)

SYDNEY, AUSTRALIA – November 12, 2018 – Immutep Limited (ASX:IMM; NASDAQ:IMMP) ("Immutep“ or “the Company“), a biotechnology company developing novel immunotherapy t...read more